In men and gender-diverse persons, twice-yearly subcutaneous lenacapavir vs. daily oral F/TDF reduced HIV incidence
Year: 2025
Type: article
Source: Annals of Internal Medicine
Author: Fred Arthur Zar
Institution: University of Illinois Chicago
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409011900
